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Glucagon and insulin both stimulated the 3*P-labelling of ribosomal protein S6 in rat hepatocytes that had 
been incubated with ‘*Pi. Glucagon selectively enhanced the labelling of the tryptic peptide phosphor- 
ylated by cyclic AMP-dependent protein kinase, demonstrating that 6 S is a physiological substrate for this 
enzyme. Insulin stimulated the phosphorylation of distinct tryptic peptides, at least one of which appears 
to be very close in the primary structure to the sites phosphorylated by cyclic AMP-dependent protein 
kinase. 
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1. INTRODUCTION 
Protein S6 of the small (40 S) ribosomal subunit 
is the major phosphoprotein of mammalian ribo- 
somes, and can be phosphorylated at multiple sites 
(at least 5) in vivo [l-3]. Phosphorylation is cata- 
lysed by cyclic AMP-dependent protein kinase in 
vitro [3,4] but only two major sites for this kinase 
appear to exist [4,5]. The existence of additional S6 
kinases is also suggested by the increased phos- 
phorylation that occurs in response to a variety of 
anabolic agents that do not act through cyclic 
AMP (e.g., [6-111). These agents include insulin, 
which promotes S6 phosphorylation in several cell 
lines, in particular Hela cells [9], pre-adipocytes 
[ 1 l] and 3T3 fibroblasts [7]. However, the role of 
insulin in vivo is uncertain as there are conflicting 
reports on the effects of insulin administration and 
diabetes on S6 phosphorylation in insulin sensitive 
tissues ([ 121 cf. [ 131). 
AMP-dependent protein kinase, and the elucida- 
tion of their sequences. The analysis surprisingly 
revealed that these two sites were mono- and di- 
phosphorylated derivatives of the same peptide 
(Arg-Leu-Ser(P)-Ser-Leu-Arg and Arg-Leu- 
Ser(P)-Ser(P)-Leu-Arg), the two phosphoserines 
being adjacent in the primary structure 141. 
Here, we have used the same methodology to 
investigate the effects of insulin and glucagon on 
S6 phosphorylation in isolated hepatocytes. It is 
demonstrated that all the detectable phosphoryla- 
tion sites on S6 can be released by brief tryptic 
digestion of whole ribosomes, and that glucagon 
stimulates the phosphorylation of the previously 
defined sites for cyclic AMP-dependent protein 
kinase. The major action of insulin is to enhance 
the phosphorylation of other sites, at least one of 
which appears to be in close proximity to the adja- 
cent phosphoserine residues. 
We have described a simple procedure for anal- 
ysing the phosphorylation sites on S6, which in- 
volves their selective release from whole ribosomes 
by brief tryptic digestion [4]. This finding greatly 
facilitated the isolation of the major tryptic pep- 
tides containing the sites phosphorylated by cyclic 
2. MATERIALS AND METHODS 
2.1. Materials 
+To whom correspondence should be addressed 
“Pi (carrier free) was obtained from Amersham 
International (Bucks); Sephadex G-25 (Superfine 
grade) from Pharmacia (GB) (Hounslow, Middle- 
sex); trypsin-treated with tosylphenylchloro- 
methylketone (Worthington) from Cambrian 
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Chemicals (Croydon, Surrey); crystalline porcine 
insulin and glucagon, products of Lilley Research 
Lab. (USA) were gifts from Dr T.S. Ingebritsen. 
Fatty acid free bovine serum albumin (Sigma 
Chemical Co., Poole, Dorset) was dialysed against 
water and lyophilised before use. 
2.2. Isolation and incubation of hepatocytes 
Hepatocytes were isolated from fed male Wistar 
rats essentially as in [ 141 with the modifications in 
[ 151. The hepatocytes were resuspended in 100 ml 
Krebs-Henseleit bicarbonate buffer containing 
20 mM glucose and 1% (w/v) albumin ( - 5 x 106 
cells/ml), gassed with 95% 02 and 5% CO2, and 
preincubated for 30 min at 37°C. The cells were 
centrifuged at 1OOxg for 1 min, and resuspended 
in 50 ml low phosphate (0.24 mM) Krebs-Hen- 
seleit bicarbonate buffer containing “Pi (100 pCi/ 
ml), 20 mM glucose and 1% albumin. The cell sus- 
pension was divided into 16 ml aliquots and incu- 
bated for 60 min. Insulin (l&8 M) or glucagon 
(10-8 M) were then added, and after an additional 
15 min, the incubations were terminated by cen- 
trifuging at 1OOxg for 1 min and cooling the cells 
on ice, in readiness for subcellular fractionation. 
In some experiments Wistar rats starved for 2 
days and refed a low-fat, high-carbohydrate diet 
(for 2 days) as in [ 161 were used. These hepatocytes 
were incubated in Eagle’s minimal essential medi- 
um containing “Pi (0.2 mM, 100 &i/ml) as in 
(161. 
Hepatocytes were routinely checked for cell 
viability by the Trypan Blue dye-exclusion test [ 171 
and for the effects of hormones on glucose output 
as in [ 181. Cell viability was generally > 88% at the 
end of the final incubation. In typical experiments 
standard hormonal responses were observed [ 181 
glucagon stimulating glucose output 3-5-fold and 
insulin suppressing the glucagon response by 40- 
50% (in a glucose free buffer). Similar hormonal 
effects were apparent after either the 30 min pre- 
incubation, or 60 min incubation in the low phos- 
phate buffer employed in 32P-labelling experi- 
ments. 
2.3. Preparationofribosomes 
The method of Thomas and co-workers [ 191 was 
modified, with the inclusion of the phosphatase in- 
hibitors, NaF and EGTA, in the isolation buffers. 
All procedures were carried out at 4°C. The cell 
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pellets were homogenised with 40 strokes of a 
Dounce glass-glass homogeniser in 4 vol. hypo- 
tonic detergent buffer (5 mM Tris-HCl (pH 7.4) 
containing 2.0 mM KCl, 2.5 mM MgCl2, 25 mM 
NaF, 1.0 mM EGTA, 0.1 mM EDTA, 0.5 mM di- 
thiothreitol, 1.5% (w/v) Triton X-100 and 1% (w/v) 
sodium deoxycholate). Immediately following ho- 
mogenisation, 0.1 vol. 100 mM Tris-HCl (pH 7.4) 
containing 1.0 M KCl, 250 mM NaF and 10 mM 
2-mercaptoethanol were added, and the suspen- 
sions centrifuged at 125 000 x g for 2.5 h. The ri- 
bosomal pellets were resuspended in 25 mM Tris- 
HCl (pH 7.4) containing 100 mM KCl, 2.5 mM 
MgCl2, 25 mM NaF, 1 .O mM EGTA, 0.1 mM 
EDTA and 0.5 mM dithiothreitol, layered over 
0.75 M sucrose in the same buffer, and centrifuged 
at 125 000 X g for 5 h. The ribosomal pellets were 
resuspended in the above buffer and centrifuged at 
10 000X g to remove debris. The recovery of 
ribosomal material in the supernatant was 4-5 mg 
RNA/ lo* hepatocytes. 
Ribosomes from starved-refed hepatocytes [ 161 
were isolated in the same manner except that de- 
tergents were omitted from the homogenisation 
buffer, and the initial 125 000 x g pellets were re- 
homogenised in hypotonic detergent buffer before 
being processed as described above. 
2.4. Selective tryptic cleavage ofwhole ribosomes 
The ribosomal suspensions (5 mg RNA/ml) 
were digested with trypsin (50 pglml) for 1.25 min 
at 33°C as in [4]. Digestions were terminated by 
the addition of 0.02 vol. 100% (w/v) trichloroacetic 
acid, and the precipitates removed by centrifuga- 
tion. The supernatants were neutralised with 
0.3 vol. 1.0 M Tris-HCl (pH 9.0) and incubated 
with trypsin (50 pg/ml) for a further 5 h at 33°C to 
ensure complete digestion [4]. Trichloroacetic acid 
(100% (w/v), 0.1 vol.) was then added, and the pre- 
cipitated trypsin removed by centrifugation. Gla- 
cial acetic acid (0.1 vol.) was added and the solu- 
tions subjected to gel filtration and subsequent iso- 
electric focussing (see section 3). 
2.5. Isolation of S6 
S6 was purified by polyacrylamide gel electro- 
phoresis at pH 4.1 in the presence of urea [20]. The 
gel section containing QP-labelled S6 was ground 
in a pestle and mortar, and the gel paste extracted 
with ethanol-ether (60:40, v/v). The gel fragments 
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were then incubated for 8 h in 200 mM Tris-HCl 
(pH 8.0) containing 50 pg trypsin/ml. The diges- 
tion was terminated by addition of 0.1 vol. 100% 
(w/v) trichloroacetic acid, and the supernatant ob- 
tained after centrifugation desalted on Sephadex 
G- 15 equilibrated in 1.0 M acetic acid. The 
[j*P]peptide fraction was lyophilised and analysed 
by isoelectric focussing (see section 2). 
3. RESULTS 
3.1. Gelfiltration of [32P]phosphopeptidesproduced 
by brief tryptic digestion of whole ribosomes 
Insulin and glucagon both enhanced the 3*P- 
labelling of ribosomal protein S6 (50% and 30%, 
respectively) in 3*P-labelled hepatocytes from nor- 
mally fed rats. The S6 protein migrated on sodium 
dodecyl sulphate-polyacrylamide gels as a closely 
spaced doublet [lo]. The effect of glucagon was 
confined to the faster migrating component(s) of 
S6 [13], while insulin selectively enhanced the 
more slowly migrating species (not shown). 
The only other protein whose 3*P-labelling was 
appreciably (50%) increased by insulin was the Mr 
46 000 peptide in the cytoplasm originally de- 
scribed in [2 l] (not shown). 
Brief tryptic digestion of the ribosomes led to 
the complete disappearance of 3*P-radioactivity 
associated with S6 and its appearance as trichloro- 
acetic acid-soluble [3*P]peptides (not shown). 
Analysis of the acid-soluble tryptic phosphopep- 
tides by gel filtration on Sephadex G-25 (fig.1) re- 
solved three p*P]peptide containing fractions, 
termed TA (V,IV, = 1.25) Tn (Fe/V0 = 1.38) 
and Tc ( V,l V, = 1.6). Fraction Tc was eluted in 
the same position as the major tryptic peptides 
phosphorylated by cyclic AMP-dependent protein 
kinase [4]. Glucagon enhanced the labelling of 
fraction Tc by 2OW, whereas insulin enhanced the 
labelling of TA by 70% and TB by 40%. An effect 
of insulin on Tc was not apparent. 
3.2. Analysis of phosphopeptides by isoelectric 
focussing 
The peak fractions from Sephadex G-25 (tig.1) 
each contained several 3*P-labelled components 
(fig.2) that were identified by comparison with the 
tryptic phosphopeptide pattern of authentic S6, 
isolated from insulin-treated hepatocytes as in 
section 2.5 (fig.2). 
The two major peptides in fraction Tc (S6-1 and 
S6-4) comigrated with the peptides (~1-8.0 and 
4.5) that are phosphorylated by cyclic AMP- 
dependent protein kinase in vitro [4]; i.e., S6-1 is 
the monophosphorylated and S6-4 the diphos- 
phorylated, derivative of the peptide Arg-Leu- 
Ser-Ser-Leu-Arg (see section 1). Peptides S6-1 
and S6-4 were both enhanced to a similar extent 
by glucagon. The ratio S6-4/S6-1 also appeared to 
be slightly enhanced by insulin (fig.2). The Tc 
fraction contained two further phosphopeptides 
0 20 40 60 60 
fraction number 
Fig. 1. Gel filtration of 3*P-labelled tryptic peptides on 
Sephadex G-25 superfine. The column (146 x 1.5 cm) 
was equilibrated with 1.0 M acetic acid. Samples 
(1.0 ml) of tryptic digests of ribosomes (6.5 mg RNA/ 
sample), were applied to the column at 18 ml/h flow- 
rate. Fractions of 1.0 ml were collected after 66 ml had 
passed through the column. The samples originated 
from control (O-O), glucagon-treated (0-e) and in 
sulin-treated (A-A) hepatocytes. The arrows P’, and N 
denote the positions of the void volume V, and 
[Y-~*P]ATP respectively. Additional [s*P]nucleotides and 
‘*Pi that eluted after fractions 70 are not shown. The 
phosphopeptides TA (fractions 17-23) Tn (26-33) and 
T, (39-50) were pooled and analysed by isoelectric 
focussing (fig.2). 
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S6-2 and S6-3. The 32P-radioactivity in S6-2 may 
have been slightly enhanced by glucagon, and that 
in S6-3 by insulin (fig.2). 
The most striking effects of insulin were in the 
TA and TB fractions, as expected from lig.1. In- 
sulin greatly enhanced the 32P-labelling of three 
bands, S6-6, S6-7 and S6-8, in fraction TA, and a 
single major band S6-5 (~1-4.3) in fraction TB 
(tig.2). Peptide S6-5 comigrated on gel filtration 
(fig. l), isoelectric focussing (fig.2) and high-perfor- 
mance liquid chromatography (not shown) with a 
minor S6-derived peptide phosphorylated by cyclic 
AMP-dependent protein kinase, termed Tla 141. 
This finding is considered further in the discussion. 
The effects of glucagon and insulin on 32P- 
labelling of S6 are unlikely to be due to changes in 
the specific radioactivity of [Y-~~P]ATP for the 
following reasons: 
Fig.2. Isoelectric focussing of 32P-labelled tryptic peptides of S6 from normally fed rats. The peak tubes from fractions 
TA (A), Ta (B) and Tc (C) in fig.1 were analysed by isoelectric focussing in polyacrylamide as in [22]. After completion 
of the isoelectric focussing, the pH gradients were estimated using a surface electrode. The identification of individual 
S6 phosphopeptides i based on the analysis of the tryptic digest of S6 purified from insulin treated hepatocytes (right 
track). The strong band immediately above S6-5 in TB fractions is not derived from S6. 
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(i) The effects of insulin were specific to a few 
peptides, other 3*P-species being relatively un- 
affected (tig.2); 
(ii) The 3*P-radioactivity eluting in the region of 
[y-s*P]ATP was hardly affected by hormones 
(fig. 1); 
(iii) The 3*P-labelling of ribosomal RNA was not 
enhanced by either hormone, and in fact 
insulin slightly inhibited this process 
(1 not shown). 
1 2 pH 
Fig.3. Isoelectric focussing of s2P-labelled tryptic pep- 
tides of S6 from starved-refed rats. The Tc fraction 
from gel filtration on Sephadex-25 (as in tig.1) was 
pooled and analysed by isoelectric focussing as in fig.2: 
The first serine in the sequence Arg-Leu-Ser- 
Ser-Leu-Arg is phosphorylated preferentially by 
cyclic AMP-dependent protein kinase in vitro [4], 
as would be expected from studies with synthetic 
peptide substrates [23]. However, the state of phos- 
phorylation of each serine residue in vivo will 
depend on the relative activities of cyclic AMP- 
dependent protein kinase and the S6 phospha- 
tase(s) that act on these sites. Therefore, which of 
the two serine residues are labelled in the mono- 
phosphorylated derivative S6- 1 (fig.2) is uncertain. 
It is also possible that one of these two adjacent 
serine residues is phosphorylated in vivo by a pro- 
tein kinase distinct from cyclic AMP-dependent 
protein kinase, and that such an enzyme is respon- 
sible for the phosphorylation of peptide S6- 1 in the 
absence of CAMP elevation. A similar situation is 
apparent in the case of skeletal muscle glycogen 
synthase (241. 
track I, control cells: track 2, glucagon-treated cells. The existence in hepatocytes of an insulin regul- 
3.3. Effects of glucagon 
starved-refed animals 
These experiments were 
largest reported effects of 
November 1982 
on hepatocytes from 
performed because the 
glucagon on the phos- 
phorylation of hepatic acetyl CoA carboxylase 
have been obtained under these conditions [16]. 
Glucagon enhanced the 3*P-labelling of S6 by 
180% in these experiments, and following tryptic 
digestion of whole ribosomes and gel filtration as 
in fig.1, the 3*P-radioactivity associated with the 
Tc fraction was enhanced by 50% (not shown). ISO- 
electric focussing showed two major [3*P]peptides 
that comigrated with S6-1 and S6-4 (fig.3). The 
proportion of the diphosphorylated species (S6-4) 
was relatively low compared with the samples 
from normally fed animals. Glucagon enhanced 
the 32P-labelling of S6-1 and S6-4, although the 
absolute increase in S6- 1 was greater. 
4. DISCUSSION 
The two major sites on S6 phosphorylated by 
cyclic AMP-dependent protein kinase in vitro are 
contained within the sequence Arg-Leu-Ser- 
Ser-Leu-Arg [4]. These results demonstrate that 
both sites are phosphorylated in isolated 
hepatocyteg, and that the phosphorylation of at 
least one of these serines is enhanced by glucagon. 
These findings prove that S6 is a physiological sub- 
strate for cyclic AMP-dependent protein kinase. 
211 
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ated S6 kinase(s) is strongly suggested by the spe- 
cific increase in the 32P-labelling of peptides dis- 
tinct from S6-1 and S6-4 (fig.2). One of the insulin 
stimulated peptides S6-5 may well be identical to 
peptide Tla isolated in [4] as a minor phosphopep- 
tide, during studies of the phosphorylation of S6 in 
vitro by cyclic AMP-dependent protein kinase. 
This peptide, which contains 3 phosphate moieties 
[4] has been shown to possess the sequence Arg- 
Leu-Ser-Ser-Leu-Arg-Ala-Ser-Thr-(Ser)- 
Lys (R.E.H.W., F.J. Morgan, in preparation). The 
third phosphorylation site is the serine 4 residues 
C-terminal to the pair of adjacent serines. How- 
ever, the failure of glucagon to enhance the 32P- 
labelling of peptide S6-5, suggests that this site is 
not phosphorylated by cyclic AMP-dependent pro- 
tein kinase in vivo. The third phosphorylation site 
may, however, be a target for the insulin-stimulat- 
ed S-6 kinase in vivo, and it is also possible that 
other insulin-stimulated peptides S6-6, S6-7 and 
S6-8 (lig.2) represent more highly phosphorylated 
derivatives of S6-5 and adjacent segments of S6. 
The multiple phosphorylation of these peptides, 
especially S6-8, is suggested by their intense label- 
ling and low PI-values (lig.2) and the presence of 4 
serines and a threonine in the 13 residues C-termi- 
nal to the pair of adjacent serines in S6-4 
(R.E.H.W., F.J. Morgan, in preparation) is consis- 
tent with this idea. Multiply phosphorylated pep- 
tides are known to elute from gel filtration col- 
umns before the singly phosphorylated derivatives 
1251, and multiple phosphorylations in this region 
might also inhibit tryptic cleavages. More detailed 
structural analysis is necessary to elucidate 
whether all the S6 phosphorylation sites are clus- 
tered within a few residues in the polypeptide 
chain. 
The finding that insulin slightly increased the 
labelling of peptide S6-4 relative to S6-1 (fig.2) 
could be explained in a variety of ways. For exam- 
ple, phosphorylation of the insulin-sensitive pep- 
tides S6-5, S6-6, S6-7 and S6-8 might alter the con- 
formation of S6 in such a way that the protein is 
phosphorylated more rapidly by cyclic AMP-de- 
pendent protein kinase. Alternatively, the insulin- 
stimulated S6 kinase might be able to phosphory- 
late one of the two adjacent serine residues, or an 
S6-phosphatase acting on one of these sites might 
be inhibited. A detailed analysis of the phosphory- 
lation of S6 by a purified preparation of the puta- 
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tive insulin stimulated S6-kinase will be needed to 
distinguish between these possibilities. 
ACKNOWLEDGEMENTS 
This work was carried out while R.E.H.W. was 
on study leave at the University of Dundee, and 
was supported by a Programme Grant from the 
British Medical Research Council to P.C. and by a 
Project Grant from the National Health and Medi- 
cal Research Council of Australia to R.E.H.W. We 
thank Drs T.S. Ingebritsen, D.G. Hardie and L.A. 
Witters for helpful discussions. 
REFERENCES 
[I] Gressner, A.M. and Wool, I.G. (1974) J. Biol. 
Chem. 249.6917-6925. 
[2] Wool, I.G. (1979) Annu. Rev. Biochem. 48, 719- 
754. 
[3] Traugh, J.A. (1981) in: Biochemical Actions of 
Hormones, vol. VIII (Litwack. G. ed) pp. 167-208. 
Academic Press, New York. 
[4] Wettenhall, R.E.H. and Cohen. P. (1982) FEBS 
Lett. 140, 263-269. 
[5] del Grande, R.W. and Traugh. J.A. (1982) Eur. J. 
I61 
171 
181 
1161 
(171 
Biochem. 123.421-428. 
Leader, D.P.. Rankine, A.D. and Coia. A.A. (1976) 
Biochem. Biophys. Res. Commun. 71,966-974. 
Haselbacher. G.K.. Humbel, R.E. and Thomas, G. 
(1979) FEBS Lett. 100, 185-190. 
Thomas, G., Siegmann, M., Kubler, A.M., Gordon, 
J. and Jimenez de Asua, L. (1980) Cell 19, 10155 
1023. 
Lastick, S.M. and McConkey, E.H. (1981) J. Biol. 
Chem. 256,583-585. 
Wettenhall, R.E.H. and Hewlett, G.J. (1979) J. Biol. 
Chem. 254,9317-9323. 
Smith, C.J., Wejksnora, P.J., Warner, J.R., Rubin, 
C.S. and Rosen, O.M. (1979) Proc. Natl. Acad. Sci. 
USA 76.2725-2729. 
Gressner, A.M. and Wool, I.G. (1976) Nature 259, 
148-150. 
Nielsen, P., Manchester, K., Towbin, H., Gordon, J. 
and Thomas, G. (1982) J. Biol. Chem. in press. 
Seglen, P.O. (1973) Exp. Cell Res. 82.391-398. 
Geelen. M.J.H., Beyner, A.C., Christiansen, R.Z.. 
Lepreau-Jose, M.J. and Gibson, D.M. (1978) FEBS 
Lett. 95,326-330. 
Witters, L.A., Kowaloff, E.M. and Avruch, J. (1979) 
J. Biol. Chem. 254, 245-248. 
Phillips, H.J. and Terryberry, J.E. (1957) Exp. Cell 
Res. 13. 34-38. 
Volume 148, number 2 FEBSLETTERS November 1982 
[ 181 Blackmore, P.F., Assimacopoulos-Jeannet, F., 
Chart, T.M. and Exton, J.H. (1979) J. Biol. Chem. 
254,2828-2834. 
[19] Thomas, G., Siegmann, M., Bowman, P.D. and 
Gordon, J. (1977) Exp. Cell Res. 108,253-258. 
(201 Kaltschmidt, E. and Wittmann, H.G. (1970) Anal. 
Biochem. 36,401-412. 
1211 Avruch, J., Witters, L.A., Alexander, M.C. and 
Bush, M.A. (1978) J. Biol. Chem. 253,4754-4761. 
[22] Hardie, D.G. and Guy, P.S. (1980) Eur. J. Biochem. 
110, 167-177. 
[23] Feramisco, J.R., Glass, D.B. and Krebs, E.G. (1980) 
J. Biol. Chem. 255,4240-4245. 
(241 Parker, P.J., Embi, N., Caudwell, F.B. and Cohen, 
P. (1982) Eur. J. Biochem. 124,47-55. 
1251 Rylatt, D.B., Aitken, A., Bilham, T., Condon, G.D., 
Embi, N. and Cohen, P. (1980) Eur. J. Biochem. 
107, 529-537. 
213 
